建立肝硬化门静脉高压食管胃底静脉曲张破裂出血急诊绿色通道的可行性、安全性及有效性

周林峰; 王万胜; 朱晓黎; 李婉慈; 唐浩桓

doi:10.3969/j.issn.1001-5256.2019.05.013

建立肝硬化门静脉高压食管胃底静脉曲张破裂出血急诊绿色通道的可行性、安全性及有效性

DOI: 10.3969/j.issn.1001-5256.2019.05.013

苏州大学附属第一医院介入科

基金项目:

江苏省重点研发计划项目(BE2017671)；苏州市临床重点病种诊疗技术专项(LCZX201704)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 517
- HTML全文浏览量: 62
- PDF下载量: 145
- 被引次数: 0
出版历程
- 收稿日期: 2018-11-23
- 出版日期: 2019-05-20

Feasibility, safety, and clinical effect of establishing a green channel for the treatment of cirrhotic portal hypertension with esophagogastric variceal bleeding

Department of Interventional Radiology, The First Affiliated Hospital of Soochow University

Research funding:

摘要

摘要: 目的探讨急诊经颈静脉肝内门体分流术（TIPS）联合食管胃底静脉曲张栓塞（EGVE）治疗门静脉高压食管胃底静脉曲张破裂出血（EGVB）绿色通道建立的可行性、安全性及有效性。方法收集2015年4月1日-2017年12月31日在苏州大学附属第一医院介入科接受TIPS+EGVE治疗的75例患者资料,其中急诊TIPS+EGVE 49例,择期TIPS+EGVE 26例。观察术后止血率、住院时间、术后1年内再出血率、围手术期及术后并发症发生率、1年内病死率等。计量资料2组间比较采用t检验,计数资料2组间比较采用χ2检验,Kaplan-Meier绘制生存曲线比较再出血率。结果 75例患者手术均成功实施,术后1周止血率100%,急诊与择期TIPS+EGVE组术后平均住院时间比较差异有统计学意义[（6. 1±1. 0） d vs （8. 1±2. 1） d,t=-4. 685,P <0. 001]。急诊TIPS+EGVE组:2例（4. 1%）出现再出血,其中1例（2. 0%）术后2个月出现再出血并死亡,另1例术后13个月出现再出血,保守治疗好转后出院; 12例（24. 5%）随...
- 肝硬化 /
- 高血压,门静脉 /
- 门体分流术,经颈静脉肝内 /
- 栓塞,治疗性 /
- 食管和胃静脉曲张 /
- 胃肠出血 /
- 回顾性研究
Abstract: Objective To investigate the feasibility, safety, and clinical effect of emergency transjugular intrahepatic portosystemic shunt ( TIPS) combined with esophagogastric variceal embolization ( EGVE) in establishing a green channel for the treatment of cirrhotic portal hypertension with esophagogastric variceal bleeding ( EGVB) . Methods A retrospective analysis was performed for the clinical data of 75 patients who underwent TIPS + EGVE in Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, from April 1, 2015 to December 31, 2017. Among these patients, 49 underwent emergency TIPS + EGVE and 26 underwent elective TIPS +EGVE. Postoperative hemostasis rate, length of hospital stay, rebleeding rate within 1 year after surgery, perioperative and postoperative complications, and mortality rate within 1 year after surgery were observed. The t-test was used for comparison of continuous data between the two groups, the chi-square test was used for comparison of categorical data between the two groups, and the Kaplan-Meier method was used to plot survival curves to compare rebleeding rate. Results All 75 patients underwent a successful surgery, with a hemostasis rate of 100% at 1 week after surgery. There was a significant difference in mean hospital stay between the emergency TIPS + EGVE group and the elective TIPS + EGVE group ( 6. 1 ± 1. 0 days vs 8. 1 ± 2. 1 days, t =-4. 685, P < 0. 001) . Among the patients in the emergency TIPS +EGVE group, 2 patients ( 4. 1%) experienced rebleeding, among whom 1 patient ( 2. 0%) experienced rebleeding and died at 2 months after surgery, and the other patient experienced rebleeding at 13 months after surgery and was cured and discharged after conservative treatment; 12 patients ( 24. 5%) had at least one episode of grade ≥2 hepatic encephalopathy during follow-up. Among the patients in the elective TIPS + EGVE group, 4 patients ( 15. 4%) experienced rebleeding after surgery, among whom 3 ( 11. 5%) died; 5 patients ( 19. 2%) had at least one episode of grade ≥2 hepatic encephalopathy, among whom one patient had three episodes of hepatic encephalopathy within one month after surgery. There were no significant differences between the two groups in cumulative rebleeding rate, mortality rate, and incidence rate of hepatic encephalopathy ( P > 0. 05) . Mean blood ammonia level reached the peak at 1 month after surgery and then gradually decreased. Among the 17 patients with hepatic encephalopathy, 11 ( 64. 7%) experienced hepatic encephalopathy within 1 month after surgery, and 15 ( 88. 2%) experienced such disease within 6 months after surgery. Conclusion Emergency TIPS combined with EGVE is feasible, safe, and effective in establishing a green channel in patients with liver cirrhosis and acute EGVB.
- liver cirrhosis /
- hypertension, portal /
- portasystemic shunt, transjugular intrahepatic /
- embolization, therapeutic /
- esophageal and gastric varices /
- gastrointestinal hemorrhage /
- retrospective studies

HTML全文

参考文献(26)

[1] BRUNNER F, BERZIGOTTI A. Prevention and treatment of variceal haemorrhage in 2017[J]. Liver Int, 2017, 37 (Suppl1) :104-115.

[2] YANG LY. Attention to the surgical treatment of portal hypertension in China[J]. Chin J Dig Surg, 2018, 17 (10) :971-975. (in Chinese) 杨连粤.重视我国门静脉高压症外科治疗的问题[J].中华消化外科杂志, 2018, 17 (10) :971-975.

[3] CHENG LF, LI CZ. A multi-center survey of esophagogastic variceal bleeding in China[J]. J Clin Hepatol, 2012, 28 (6) :462-464. (in Chinese) 程留芳, 李长政.全国多中心食管胃静脉曲张出血调查[J].临床肝胆病杂志, 2012, 28 (6) :462-464.

[4] GAZZERA C, RIGHI D, DORIGUZZI BA, et al. Emergency transjugular intrahepatic portosystemic shunt (TIPS) :Results, complications and predictors of mortality in the first month of followup[J]. Radiol Med, 2012, 117 (1) :46-53.

[5] REIBERGER T, ULBRICH G, FERLITSH A, et al. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol[J]. Gut, 2013, 62 (11) :1634-1641.

[6] SAUERBRUCH T, MENGEL M, DOLLINGER M, et al. Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents vs. hemodynamically controlled medical therapy[J]. Gastroenterology, 2015, 149 (3) :e661.

[7] STRUNK H. Transjugular intrahepatic portosystemic shunt (TIPS) :Pathophysiologic basics, actual indications and results with review of the literature[J]. RFo, 2018, 190 (8) :701-711.

[8] de FRANCHIS R, BAVENO VIF. Expanding consensus in portal hypertension:Report of the Baveno VI Consensus Workshop:Stratifying risk and individualizing care for portal hypertension[J]. J Hepatol, 2015, 63 (3) :743-752.

[9] GARCIA-TSAO G, ABRALDES JG, BERZIGOTTI A, et al.Portal hypertensive bleeding in cirrhosis:Risk stratification, diagnosis, and management:2016 practice guidance by the American Association for the study of liver diseases[J]. Hepatology, 2017, 65 (1) :310-335.

[10] Interventional Group, Chinese Society of Radiology, Chinese Medical Association, Expert consensus on transjugular intrahepatic portosystemic shunt[J]. J Clin Hepatol, 2017, 33 (7) :1218-1228. (in Chinese) 中华医学会放射学分会介入学组.经颈静脉肝内门体分流术专家共识[J].临床肝胆病杂志, 2017, 33 (7) :1218-1228.

[11] GARCÍA-PAGÁN JC, CACA K, BUREAU C, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding[J]. N Engl J Med, 2010, 362 (25) :2370-2379.

[12] HALABI SA, SAWAS T, SADAT B, et al. Early TIPS versus endoscopic therapy for secondary prophylaxis after management of acute esophageal variceal bleeding in cirrhotic patients:A meta-analysis of randomized controlled trials[J]. J Gastroenterol Hepatol, 2016, 31 (9) :1519-1526.

[13] SHI JS, MU XF, CHEN S, et al. Proposal of vascular interventional therapy as a fast passage and the first choice in treatment of acute severe upper gastrointestinal bleeding[J/CD].Chin J Inter Rad:Electronic Edition, 2017, 5 (3) :170-173. (in Chinese) 史键山, 牟雪枫, 陈松, 等.构建以介入为首选的急性重度上消化道出血急诊绿色通道[J/CD].中华介入放射学电子杂志, 2017, 5 (3) :170-173.

[14] SARIN SK, LAHOTI D, SAXENA SP, et al, Prevalence, classification and natural history of gastric varices:A long-term follow-up study in 568 portal hypertension patients[J]. Hepatology 1992, 16 (6) :1343-1349.

[15] YU J, WANG X, JIANG M, et al. Comparison of transjugular intrahepatic portosystemic shunt (TIPS) alone and combined with embolisation for the management of cardiofundal varices:A retrospective study[J]. Eur Radiology, 2019, 29 (2) :699-706.

[16] CHEN JH, LIU ZY, YUAN WZ, et al. Retrospective study of TIPS combined with gastric coronary vein embolization for portal hypertension complicated with upper gastrointestinal bleeding[J]. J Chin Surg, 2018, 26 (5) :334-337. (in Chinese) 陈锦皇, 刘正义, 袁文正, 等.经颈内静脉肝内门体分流术联合胃冠状静脉栓塞术治疗门静脉高压症伴上消化道出血的回顾性研究[J].临床外科杂志, 2018, 26 (5) :334-337.

[17] CHEN S, LI X, WEI B, et al. Recurrent variceal bleeding and shunt patency:Prospective randomized controlled trial of transjugular intrahepatic portosystemic shunt alone or combined with coronary vein embolization[J]. Radiology, 2013, 268 (3) :900-906.

[18] SHI Y, TIAN X, HU J, et al. Efficacy of transjugular intrahepatic portosystemic shunt with adjunctive embolotherapy with cyanoacrylate for esophageal variceal bleeding[J]. Dig Dis Sci, 2014, 59 (9) :2325-2332.

[19] de FRANCHIS R, PRIMIGNANI M. Why do varices bleed?[J].Gastroenterol Clin North Am, 1992, 21 (1) :85.

[20] CELLO JP, RING EJ, OLCOTT EW, et al. Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial[J].Ann Intern Med, 1997, 126 (11) :858-865.

[21] MA YJ, GONG Z, CHI Y, et al. Evaluation of emergency transjugular intrahepatic portosystemic shunt in the treatment of variceal bleeding in liver cirrhosis[J]. J Chin Clin Med Imaging, 2017, 28 (12) :888-892. (in Chinese) 马羽佳, 龚正, 迟源, 等.急诊经颈静脉肝内门体分流术治疗肝硬化静脉曲张出血的疗效评价[J].中国临床医学影像杂志, 2017, 28 (12) :888-892.

[22] TRIPATHI D, STANLEY AJ, HAVES PC, et al. UK guidelines on the management of variceal haemorrhage in cirrhotic patients[J]. Gut, 2015, 64 (11) :1680-1704.

[23] GARCA-PAGN JC, di PASCOLI M, CACA K, et al. Use of early-TIPS for high-risk variceal bleeding:Results of a postRCT surveillance study[J]. J Hepatol, 2013, 58 (1) :45-50.

[24] NIEI B, MCCARTY TR. Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding[J]. J Gastroenterol Hepatol, 2017, 32 (4) :852-858.

[25] BOSCH J, ABRALDES JG, ALBILLOS A, et al. Portal hypertension:Recommendations for evaluation and treatment:Consensus document sponsored by the Spanish Association for the Study of the Liver (AEEH) and the Biomedical Research Network Center for Liver and Digestive Diseases (CIBERehd) [J]. Gastroenterol Hepatol, 2012, 35 (6) :421-450.

[26] LOPERA JE. Role of emergency transjugular intrahepatic portosystemic shunts[J]. Semin Intervent Radiol, 2005, 22 (4) :253-265.

施引文献

资源附件(0)

访问统计